What we do
New start-up Patholyt will bring AI research into pathology diagnostics21 September 2021
Patholyt is on a mission to accelerate the adoption of artificial intelligence in pathology diagnostics and improve the chances of cancer patients worldwide. Patholyt is a spin-off from Radboudumc, a frontrunner in computational pathology research.
Radboudumc and SyncVR Medical looking to boost the use of virtual reality in healthcare15 July 2021
Aiming to provide better care with the help of virtual reality applications, Radboudumc is going to collaborate intensively with startup SyncVR Medical. To this end, the two partners signed a two-year collaboration agreement.
Sonlicromanol seems promising for certain cancers Khondrion announces publication in PLOS ONE of new research13 July 2021
Khondrion announces publication in PLOS ONE of new research showing normalisation of prostate cancer stem cell mPGES-1 overexpression and inhibition of cancer spheroid growth by sonlicromanol’s active metabolite.